Assessment:<div>1. Clinical evidence of reduced bone mineral density.</div><div>2. History of fragility fracture, </div><div>3. DEXA scan consistent with reduced bone mineral density and increased risk of fracture.</div><div>4. No history of osteosarcoma or prior radiation treatment.</div><div>5. No prior treatment with Forteo or Tymlos.</div><div>6. PTH, CMP, serum calcium, vitamin D, Alk Phos all within normal limits.<br></div><div>Plan:</div><div>1. Order {{Tymlos|Forteo}} sq daily x 30 days, 2 refills, samples and starter pack given.</div><div>2. Risks and expected benefits of {{Tymlos|Forteo}} treatment discussed with patient.<div><div>3. Followup in 8 weeks.</div>